Therapeutics and mild cognitive impairment: Current status and future directions

被引：7
|
作者：
Thal, LJ [1 ]
机构：
[1] Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA
来源：
ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 2003年 / 17卷
关键词：
D O I：
10.1097/00002093-200304002-00012
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S69 / S71
页数：3
相关论文
共 50 条
  • [31] Status and Future Directions of Therapeutics and Prognosis of Cardiac Amyloidosis
    Zhang, Wenbing
    Ding, Jian
    Wang, Wenhai
    Wang, Duo
    Pan, Yinping
    Xu, Dexin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 581 - 597
  • [32] Corneal abrasions in space: current therapeutics and future directions
    Ethan Waisberg
    Joshua Ong
    Andrew G. Lee
    Eye, 2024, 38 : 1238 - 1239
  • [33] Corneal abrasions in space: current therapeutics and future directions
    Waisberg, Ethan
    Ong, Joshua
    Lee, Andrew G.
    EYE, 2024, 38 (07) : 1238 - 1239
  • [34] Cognitive behavior therapies for psychotic disorders: Current empirical status and future directions
    Gaudiano, BA
    CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2005, 12 (01) : 33 - 50
  • [35] Bevacizumab - current status and future directions
    Midgley, R
    Kerr, D
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 999 - 1004
  • [36] Treatment of cognitive deficits in brain tumour patients: current status and future directions
    Coomans, Marijke B.
    van der Linden, Sophie D.
    Gehring, Karin
    Taphoorn, Martin J. B.
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 540 - 547
  • [37] Current status and future directions of The Annals
    Nahata, MC
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) : 321 - 322
  • [38] Colletotrichum - current status and future directions
    Cannon, P. F.
    Damm, U.
    Johnston, P. R.
    Weir, B. S.
    STUDIES IN MYCOLOGY, 2012, (73) : 181 - 213
  • [39] Vasculitis: Current status and future directions
    Youinou, Pierre
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 35 (1-2) : 1 - 4
  • [40] Vasculitis: Current Status and Future Directions
    Pierre Youinou
    Clinical Reviews in Allergy & Immunology, 2008, 35 : 1 - 4
12345